Ligand Pharmaceuticals (LGND)

LIGAND PHARMACEUTICALS INCORPORATED • Allergan Ligand Retinoid Therapeutics, Inc. • Aramed Inc. • Cita NeuroPharmaceuticals Inc. • CyDex Pharmaceuticals, Inc. • LHNC, Inc. • Ligand Holdings UK Limited • Ligand JVR, Inc. • Ligand Pharmaceuticals International, Inc. • Ligand UK Development Limited ...

IRS number

770160744

LGND stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$146.25

Low target

$135.00

High target

$160.00

Latest filings (excl ownership)

View all

8 Nov 24

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

7 Aug 24

Ligand Reports Second Quarter 2024 Financial Results

6 Aug 24

8-K

Departure of Directors or Certain Officers

2 Aug 24

8-K

Completion of Acquisition or Disposition of Assets

17 Jul 24

8-K

Entry into a Material Definitive Agreement

10 Jul 24

S-8

Registration of securities for employees

9 Jul 24

8-K

Ligand to Acquire APEIRON Biologics AG for $100 Million

Transcripts

View all

LGND

Earnings call transcript

2024 Q3

7 Nov 24

LGND

Earnings call transcript

2024 Q2

6 Aug 24

LGND

Earnings call transcript

2024 Q1

7 May 24

LGND

Earnings call transcript

2023 Q4

27 Feb 24

LGND

Earnings call transcript

2023 Q3

8 Nov 23

LGND

Earnings call transcript

2023 Q2

8 Aug 23

LGND

Earnings call transcript

2023 Q2

8 Aug 23

LGND

Earnings call transcript

2023 Q1

4 May 23

LGND

Earnings call transcript

2022 Q4

22 Feb 23

LGND

Earnings call transcript

2022 Q3

8 Nov 22

Latest ownership filings

View all

Octavio Espinoza

26 Dec 24

144

Notice of proposed sale of securities

Notice of proposed sale of securities

27 Nov 24

SC 13G/A

JANUS HENDERSON GROUP PLC

14 Nov 24

144

Notice of proposed sale of securities

12 Nov 24

SC 13G/A

GOLDMAN SACHS GROUP INC

Financial summary

Financial statements Chart LGND financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	63.62 mm	63.62 mm	63.62 mm	63.62 mm	63.62 mm	63.62 mm
Cash burn (monthly)	(no burn)	(no burn)	2.11 mm	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	n/a	8.50 mm	n/a	n/a	n/a
Cash remaining	n/a	n/a	55.12 mm	n/a	n/a	n/a
Runway (months of cash)	n/a	n/a	26.1	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

LGND institutional ownership history Ownership history

95.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	239	230	+3.9%
Opened positions	40	44	-9.1%
Closed positions	31	29	+6.9%
Increased positions	96	78	+23.1%
Reduced positions	50	71	-29.6%

13F shares	Current	Prev Q	Change
Total value	1.72 tn	1.39 tn	+24.1%
Total shares	18.01 mm	17.12 mm	+5.2%
Total puts	9.30 k	7.80 k	+19.2%
Total calls	26.80 k	61.00 k	-56.1%
Total put/call ratio	0.3	0.1	+171.4%

Largest owners	Shares	Value	Change
BlackRock	3.00 mm	$300.23 bn	NEW
Vanguard	1.97 mm	$197.24 bn	+2.3%
JHG Janus Henderson	1.01 mm	$101.00 bn	+0.0%
MQBKY Macquarie Group Limited	887.28 k	$88.81 bn	-8.2%
STT State Street	707.41 k	$70.81 bn	+2.7%
Dimensional Fund Advisors	707.02 k	$70.76 bn	-0.2%
Stephens Investment Management	618.70 k	$61.93 bn	-5.1%
Congress Asset Management	604.04 k	$60.46 bn	+3.0%
Chicago Capital	545.82 k	$54.63 bn	+6.0%
Villere ST Denis J & Co	474.86 k	$47.53 bn	-1.9%

Largest transactions	Shares	Bought/sold	Change
BlackRock	3.00 mm	+3.00 mm	NEW
BLK BlackRock	0.00	-2.87 mm	EXIT
Cardinal Capital Management	0.00	-133.67 k	EXIT
Granite Investment Partners	118.00 k	+118.00 k	NEW
Loomis Sayles & Co L P	372.78 k	+114.44 k	+44.3%
Penn Capital Management	100.22 k	+100.22 k	NEW
Driehaus Capital Management	95.74 k	+95.74 k	NEW
Knott David M Jr	0.00	-85.00 k	EXIT
CIBC World Markets	84.13 k	+84.13 k	NEW
PRS Prudential Financial, Inc. 5.62	101.64 k	+83.72 k	+467.2%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

LGND insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 Dec 24	Octavio Espinoza	Common Stock	Sell	Dispose S	No	No	116.3738	2,104	244.85 k	20,647
5 Dec 24	Octavio Espinoza	Common Stock	Payment of exercise	Dispose F	No	No	123.51	1,859	229.61 k	22,751
27 Nov 24	Lamattina John L	Common Stock	Sell	Dispose S	No	No	123.65	2,406	297.50 k	29,515
27 Nov 24	Lamattina John L	Common Stock	Option exercise	Acquire M	No	No	52.3	2,406	125.83 k	31,921
27 Nov 24	Lamattina John L	NQSO Common Stock	Option exercise	Dispose M	No	No	52.3	2,406	125.83 k	0
23 Sep 24	Andrew Reardon	Common Stock	Sell	Dispose S	No	No	99.6005	2,000	199.20 k	22,534
23 Sep 24	Andrew Reardon	Common Stock	Option exercise	Acquire M	No	No	52.27	2,000	104.54 k	24,534
23 Sep 24	Andrew Reardon	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	52.27	2,000	104.54 k	70,944
20 Sep 24	Octavio Espinoza	Common Stock	Sell	Dispose S	No	No	103.95	800	83.16 k	24,610
20 Sep 24	Octavio Espinoza	Common Stock	Sell	Dispose S	No	No	103.8625	275	28.56 k	25,410